Year archive

POOLBEG PHARMA PLC — 2025 filings

All 35 regulatory filings released by POOLBEG PHARMA PLC (POLB) in 2025, sourced directly from the official regulator.

35 Filings

2025 Period

2025 filings (35)

Filing	Released	Lang
Letter to Shareholders – 2025 a year of progress Regulatory Filings	2025-12-18	English
POLB 001 to feature in CRS research programme Regulatory Filings	2025-12-08	English
POLB 001 European Patent granted Regulatory Filings	2025-11-20	English
Interim Results for the six months to 30 June 2025 Interim / Quarterly Report H1 2025	2025-09-29	English
POLB 001 Phase 2a Trial Update Regulatory Filings	2025-09-25	English
Notification of Major Holdings Major Shareholding Notification	2025-07-01	English
Notification of Major Holdings Major Shareholding Notification	2025-06-26	English
Director/PDMR Shareholding Director's Dealing	2025-06-25	English
Results of GM and AGM Meetings AGM Information	2025-06-23	English
FDA Orphan Drug Designation granted for POLB 001 Regulatory Filings	2025-05-27	English
Annual Report, AGM Notice & Circular AGM Information	2025-05-27	English
Result of upsized oversubscribed BookBuild Offer Capital/Financing Update	2025-05-23	English
Increase of BookBuild Offer Capital/Financing Update	2025-05-22	English
Result of Placing and Notice of General Meeting Capital/Financing Update	2025-05-20	English
Proposed Retail Offer to raise up to £100,000 Capital/Financing Update	2025-05-20	English
Proposed Fundraising to raise approximately £4.1M Capital/Financing Update	2025-05-20	English
Results for the year ended 31 December 2024 Earnings Release FY 2024	2025-05-20	English
Conference Participation in March & April 2025 Regulatory Filings	2025-03-27	English
POLB 001 Patent Granted in Korea Regulatory Filings	2025-03-20	English
Termination of proposed combination with HOOKIPA M&A Activity	2025-02-21	English
Holding(s) in Company Major Shareholding Notification	2025-02-18	English
Form 8.3 - Poolbeg Pharma plc Director's Dealing	2025-02-18	English
Offer Update - Extension to PUSU Deadline Regulatory Filings	2025-01-30	English
Replacement - Form 8.3 - Poolbeg Pharma plc Director's Dealing	2025-01-17	English
Form 8.3 - Poolbeg Pharma plc Director's Dealing	2025-01-17	English
Form 8.3 - Poolbeg Pharma plc Director's Dealing	2025-01-16	English
Form 8.3 - Poolbeg Pharma plc Major Shareholding Notification	2025-01-15	English
Form 8.3 - Poolbeg Pharma plc Regulatory Filings	2025-01-14	English
Form 8.3 - Poolbeg Pharma plc Director's Dealing	2025-01-14	English
Form 8.3 - Poolbeg Pharma plc Regulatory Filings	2025-01-13	English
Update Potential Combination of Poolbeg & HOOKIPA M&A Activity	2025-01-10	English
Holding(s) in Company Major Shareholding Notification	2025-01-09	English
Form 8 (OPD) - Poolbeg Pharma plc Regulatory Filings	2025-01-08	English
Update Potential Combination of Poolbeg & HOOKIPA Regulatory Filings	2025-01-07	English
Combination of Poolbeg and HOOKIPA Pharma Inc. M&A Activity	2025-01-02	English